SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-093927
Filing Date
2014-03-11
Accepted
2014-03-11 17:11:09
Documents
7
Period of Report
2014-04-21
Effectiveness Date
2014-03-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d672020ddef14a.htm DEF 14A 676562
2 GRAPHIC g672020g18x30.jpg GRAPHIC 4436
3 GRAPHIC g672020g46y86.jpg GRAPHIC 7878
4 GRAPHIC g672020g48l77.jpg GRAPHIC 38326
5 GRAPHIC g672020g63g04.jpg GRAPHIC 40732
6 GRAPHIC g672020g89w61.jpg GRAPHIC 15174
7 GRAPHIC g672020g98h22.jpg GRAPHIC 51805
  Complete submission text file 0001193125-14-093927.txt   896727
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 14685047
SIC: 2836 Biological Products, (No Diagnostic Substances)